NA
Neil Gregory Almstead
Chief Technical Ops Officer

Neil Gregory Almstead insider trades: Ptc Therapeutics (PTCT) stock sales

Chief Technical Ops Officer, Ptc Therapeutics Last trade Jul 9, 2026 58 Form 4 filings
$20.1M
Sold, last 12 months
14 sales
$0
Bought, last 12 months
0 buys
66
Open-market trades
since 2014
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Neil reports to the SEC

Open-market buys and sales

66 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 9, 2026PTCT↓ Sell$222K
Jul 7, 2026PTCT↓ Sell$4.1M
Jun 26, 2026PTCT↓ Sell$693K
Jun 22, 2026PTCT↓ Sell$1.9M
Apr 1, 2026PTCT↓ Sell$3.6M
Mar 5, 2026PTCT↓ Sell$253K
Feb 18, 2026PTCT↓ Sell$212K
Feb 18, 2026PTCT↓ Sell$5K
Jan 8, 2026PTCT↓ Sell$67K
Jan 8, 2026PTCT↓ Sell$5K
Jan 7, 2026PTCT↓ Sell$178K
Jan 7, 2026PTCT↓ Sell$8K
Nov 25, 2025PTCT↓ Sell$6.0M
Nov 24, 2025PTCT↓ Sell$2.9M
Oct 3, 2025PTCT↓ Sell$3.6M
Feb 20, 2025PTCT↓ Sell$144K
Feb 20, 2025PTCT↓ Sell$3K
Jan 8, 2025PTCT↓ Sell$126K
Jan 8, 2025PTCT↓ Sell$7K
Dec 2, 2024PTCT↓ Sell$3.6M
Dec 2, 2024PTCT↓ Sell$107K
Jan 30, 2024PTCT↓ Sell$17K
Jan 30, 2024PTCT↓ Sell$763
Jan 9, 2024PTCT↓ Sell$80K
Jan 9, 2024PTCT↓ Sell$4K
Jan 31, 2023PTCT↓ Sell$29K
Jan 31, 2023PTCT↓ Sell$1K
Jan 24, 2023PTCT↓ Sell$2K
Jan 11, 2023PTCT↓ Sell$37K
Jan 11, 2023PTCT↓ Sell$2K
Jan 9, 2023PTCT↓ Sell$30K
Jan 9, 2023PTCT↓ Sell$2K
Feb 1, 2022PTCT↓ Sell$24K
Feb 1, 2022PTCT↓ Sell$1K
Jan 25, 2022PTCT↓ Sell$2K
Jan 7, 2022PTCT↓ Sell$29K
Jan 7, 2022PTCT↓ Sell$2K
Jan 4, 2022PTCT↓ Sell$3K
Feb 1, 2021PTCT↓ Sell$55K
Feb 1, 2021PTCT↓ Sell$2K
Jan 25, 2021PTCT↓ Sell$34K
Jan 8, 2021PTCT↓ Sell$90K
Jan 5, 2021PTCT↓ Sell$31K
Jan 5, 2021PTCT↓ Sell$8K
Jan 4, 2021PTCT↓ Sell$6.3M
Jan 4, 2021PTCT↓ Sell$36K
Nov 4, 2020PTCT↓ Sell$1.4M
Feb 6, 2020PTCT↓ Sell$2.8M
Feb 6, 2020PTCT↓ Sell$244K
Jan 23, 2020PTCT↓ Sell$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PTCT insiders

Open-market trades in the last 12 months

About Neil Gregory Almstead's insider trades

Neil Gregory Almstead is Chief Technical Ops Officer at Ptc Therapeutics (PTCT). Since Mar 19, 2014, Neil has reported no open-market purchases and 66 sales worth $44.2M on SEC Form 4. In the last 12 months: 14 sales ($20.1M).

1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include option exercises (16 filings), grants and awards (13 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.